PharmGKB summary: sorafenib pathways

Pharmacogenet Genomics. 2017 Jun;27(6):240-246. doi: 10.1097/FPC.0000000000000279.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Gene Regulatory Networks
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Niacinamide / analogs & derivatives*
  • Niacinamide / pharmacokinetics
  • Niacinamide / therapeutic use
  • Pharmacogenomic Testing
  • Pharmacogenomic Variants
  • Phenylurea Compounds / pharmacokinetics*
  • Phenylurea Compounds / therapeutic use
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Niacinamide
  • Sorafenib